Literature DB >> 27207852

RJ Reynolds has not published a negative randomised clinical trial of Camel Snus for smoking cessation.

Eunice E Neeley1, Stanton A Glantz1,2.   

Abstract

Entities:  

Keywords:  Cessation; Non-cigarette tobacco products; Tobacco industry documents

Mesh：

Substances：

Year:  2016        PMID： 27207852      PMCID： PMC5116427          DOI： 10.1136/tobaccocontrol-2016-052913

Source DB:  PubMed          Journal:  Tob Control        ISSN： 0964-4563            Impact factor:   7.552


× No keyword cloud information.
  3 in total

1.  Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.

Authors:  Michael Kotlyar; Louise A Hertsgaard; Bruce R Lindgren; Joni A Jensen; Steven G Carmella; Irina Stepanov; Sharon E Murphy; Stephen S Hecht; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-10       Impact factor: 4.254

2.  Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.

Authors:  Dorothy K Hatsukami; Herbert Severson; Amanda Anderson; Rachael Isaksson Vogel; Joni Jensen; Berry Broadbent; Sharon E Murphy; Steven Carmella; Stephen S Hecht
Journal:  Tob Control       Date:  2015-05-19       Impact factor: 7.552

3.  Prospective cohort study of the effectiveness of smoking cessation treatments used in the "real world".

Authors:  Daniel Kotz; Jamie Brown; Robert West
Journal:  Mayo Clin Proc       Date:  2014-10       Impact factor: 7.616
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.